- Home
- AEIS vs BMRN Comparison
AEIS vs BMRN Comparison
Compare AEIS & BMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AEIS | BMRN |
|---|---|---|
| Founded | 1981 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.8B | 10.4B |
| IPO Year | 1996 | 1999 |
Fundamental Metrics
Financial Performance| Metric | AEIS | BMRN |
|---|---|---|
| Price | $301.00 | $57.21 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 18 |
| Target Price | ★ $307.73 | $88.22 |
| AVG Volume (30 Days) | 919.2K | ★ 2.1M |
| Earning Date | 05-04-2026 | 05-04-2026 |
| Dividend Yield | ★ 0.11% | N/A |
| EPS Growth | ★ 168.53 | N/A |
| EPS | ★ 1.58 | 0.54 |
| Revenue | $453,095,000.00 | ★ $1,313,646,000.00 |
| Revenue This Year | $22.53 | $15.02 |
| Revenue Next Year | $13.38 | $12.23 |
| P/E Ratio | $200.87 | ★ $97.67 |
| Revenue Growth | ★ 38.39 | 17.62 |
| 52 Week Low | $112.72 | $49.26 |
| 52 Week High | $397.44 | $66.28 |
Technical Indicators
Market Signals| Indicator | AEIS | BMRN |
|---|---|---|
| Relative Strength Index (RSI) | 37.31 | 61.54 |
| Support Level | $292.32 | $51.74 |
| Resistance Level | $355.00 | $56.91 |
| Average True Range (ATR) | 16.72 | 1.72 |
| MACD | -2.51 | 0.44 |
| Stochastic Oscillator | 17.14 | 98.01 |
Price Performance
Historical ComparisonAbout AEIS Advanced Energy Industries Inc.
Advanced Energy Industries Inc provides precision power conversion, measurement, and control solutions. The company designs, manufactures, sells, and services power electronics conversion products that transform raw electrical power into controllable, usable power for complex equipment. It operates in one reporting segment, Power Electronics Conversion Products, serving the Semiconductor Equipment, Data Center Computing, Industrial and Medical, and Telecom and Networking markets. Its products include Plasma Power Products, AC-DC Power Supply Units, DC-DC Converters, High Voltage solutions, SCR Power Controllers, and Sense and Measurement solutions. The company operates in the United States, Asia, Europe, and other regions.
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.